IN FOCUS FEATURE
The BT Catalyst Interview with Jason Nelson
FROM OUR WEB SITE
From Our Web Site
GSK Collaboration with Danish Biotech Worth up to $700M
GlaxoSmithKline has optioned the rights to five anti-viral treatments currently under development by Santaris Pharma, from Copenhagen, Denmark.
N.C. Pavilion Sponsors Sought for BIO 2008
The N.C. Department of Commerce is accepting sponsorships for the pavilion-style exhibit at this year's BIO International Convention in San Diego, Calif.
Business Insights Deal Struck for Small Biotechs
Companies with fewer than 20 employees can now purchase reduced-cost electronic access to Business Insights market research reports.
In Focus
The BT Catalyst Interview with Jason Nelson
Jason Nelson is the special projects manager for the Biotechnology Center. One of those projects occupies most of his time: staffing and supporting the fledging Biofuels Center of North Carolina.
The non-profit corporation will be headquartered at the newly established North Carolina Biofuels Campus in Oxford on the site of the former U.S. Department of Agriculture tobacco research facility.
In this interview, Nelson discusses national models of biofuels development, the strategic plan’s immediate objectives and whether genes hold the key to another fuel source.
News from Other Sites
Selma May Get Ethanol Plant, 45 Jobs
"A South Carolina company is planning a large ethanol plant near Selma, joining other companies scrambling to meet new legislative mandates for the alternative fuel."
From the (Raleigh) News and Observer
Company's Aim, Better Drugs for Poor
"Diseases that infect millions of people too poor to pay for medicine have fascinated Yves Ribeill for about 20 years. ... Now Ribeill, CEO of Durham drug chemistry company Scynexis, found a way to combine his passion with his business."
From the (Raleigh) News and Observer
2008 Might Yield Big Moves for Tiny Science
"The pursuit of nanotechnology as a viable industry niche – one that could prove analogous to Research Triangle Park's prominence in biotech – has been a high priority to area economic developers for years, and a number of their efforts are due to come together in 2008."
From The Triad Business Journal
Business Journal Names Top Stories
The Triangle Business Journal highlighted Durham-based Quintiles' growth in the Research Triangle region and worldwide as the top business story of 2007. INC Research's expansion came in at number five and Constella's sale to SRA International was ninth.
Read the short profiles of:
Trees by Design
(North Carolina researchers quoted)
"The technology they are using is the genetic engineering that has transformed medicine and agriculture. ... But now it is being applied to trees, raising new possibilities for industry and conservation, as well as new kinds of environmental safety concerns. "
From The Boston Globe
Community Watch
- Quintiles Transnational has formed a new ownership team that includes Chairman and CEO Dennis Gillings, Bain Capital, TPG Capital, 3i and Temasek Holdings. More.
- Aldagen appointed Dr. Laurance Keller as its Chief Medical Officer. Keller previously worked on clinical drug development at Kos Pharmaceuticals and Pfizer/Park Davis. More.
- Raleigh-based BioDelivery Sciences International named former GlaxoSmithKline vice president Charles E. Dadswell General Counsel and Director, Contracts Management and Intellectual Property. More.
- The Triangle Business Journal named Dennis Gillings, chairman and CEO of Quintiles Transnational, as businessman of the year. More.
Please send Community Watch items to Jim Shamp.
Save the Date
Mar. 6
MedTech 2008
(Durham)
May 19-20
Biotech 2008
(Winston-Salem)
June 17-20
BIO 2008 Conference
(San Diego)
View our complete listing of events across North Carolina.
This newsletter was sent Thursday, Jan. 3, 2008. For the latest North Carolina biotechnology industry headlines, please visit the news section of our Web site.
Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.